Emmes, a global, full-service Clinical Research Organization (CRO), has acquired Institut Dr. Schauerte, a CRO headquartered in Munich, Germany.  Institut Dr. Schauerte is a full-service, technology-oriented CRO that specializes in late-phase, non-interventional, and post-market clinical follow-up studies.  It has conducted more than 400 studies across a range of therapeutic areas.    This is the third acquisition for Emmes in the last year, having previously purchased Neox, headquartered in t...